it'll drop off. the revenue growth of 15% with no profit despite...

  1. 4,567 Posts.
    lightbulb Created with Sketch. 348
    it'll drop off. the revenue growth of 15% with no profit despite the already 1.5billion addressable market suggests limited traction going forward. Adding additional addressable market isnt resulting in much cumulative growth in its history so far. Addressable markets have limited applicability to medicine anyway, as medicine is subjective.

    This is no Polynovo or Avita medical, which had 100-200% huge revenue growth(prior to covid-19). Avita has gone off the boil completely. This has not even a tenth of that growth and prospects.
    Last edited by Nige456: 07/07/20
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.